Comparison of EBOV GP IgG Antibody Reactivity: Results from Two Immunoassays in the Democratic Republic of the Congo

By sjmartinez • April 8, 2025

Merritt S, Halbrook M, Kompany JP, Chandrasekaran P, Smith OA, Hoff NA, Tambu M, Martin SA, Wong TA, Jarra A, Barrall AL, Musene K, Beya M, Orr R, Myers T, MacGill T, Hensley LE, Muyembe-Tamfum JJ, Kaba D, Berry IM, Mbala-Kingebeni P, Lehrer AT, Rimoin AW. Comparison of EBOV GP IgG Antibody Reactivity: Results from Two Immunoassays in the Democratic Republic of the Congo. J Virol Methods. 2025 Apr 5:115154. doi: 10.1016/j.jviromet.2025.115154. Epub ahead of print. PMID: 40194662.

Tags: Democratic Republic of the Congo, EBOV GP, immunoassays, Infectious Diseases, Publications, serosurveillance

Preferences for HIV prevention conditional cash transfers among Black/African American and Latinx cisgender MSM in Los Angeles

Moucheraud C, Trujillo D, Wagner Z, Garland W, Smith T, Hoffman RM, Landovitz RJ. Preferences for HIV prevention conditional cash transfers among Black/African American and[...]

PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town

Pike C, Rousseau E, Macdonald P, Mapukata P, Lebelo K, Joseph-Davey D, Little F, Bekker LG. PrEPared to choose: the protocol for an implementation study[...]

The Effectiveness of Isoniazid Preventive Treatment among Contacts of Multidrug-Resistant Tuberculosis: A Systematic Review and Individual-Participant Meta-Analysis

Martinez L, Campbell JI, Linde L, Boulahbal F, Cayla JA, Chakhaia T, Chan PC, Chen C, Fang CT, Fox G, Grandjean L, Hannoun D, Hesseling[...]